Showing results (1-10 of 247) with videos related to
Sort By:
Pageof 25
European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2007
Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugsJan Booij, Paul KempJournal of the Neurological Sciences|August 16, 2011
Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathwayJan Booij, Henk W BerendseHandbook of Experimental Pharmacology|November 7, 2012
Imaging as tool to investigate psychoses and antipsychoticsJan Booij, Thérèse van AmelsvoortPsychopharmacology|August 29, 2016
The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studiesYosta Vegting, Liesbeth Reneman, Jan BooijEuropean Journal of Nuclear Medicine and Molecular Imaging|March 24, 2010
The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young menElsmarieke van de Giessen, Jan BooijParkinsonism & Related Disorders|November 19, 2008
SPECT imaging of the dopaminergic system in (premotor) Parkinson's diseaseJan Booij, Remco J J KnolNuclear Medicine and Biology|March 21, 2006
Brain kinetics of the new selective serotonin transporter tracer [(123)I]ADAM in healthy young adultsJan Booij, Maartje M L de WinNuclear Medicine and Biology|April 25, 2006
Repeated administration of D-amphetamine induces loss of [123I]FP-CIT binding to striatal dopamine transporters in rat brain: a validation studyJan Booij, Kora de Bruin, W Boudewijn GunningEuropean Journal of Nuclear Medicine and Molecular Imaging|April 22, 2008
SPECT imaging of D2 dopamine receptors and endogenous dopamine release in miceCynthia Jongen, Kora de Bruin, Freek Beekman, et al.American Journal of Medical Genetics. Part A|December 15, 2012
Increase in central striatal dopamine transporters in patients with Shwachman-Diamond syndrome: additional evidence of a brain phenotypeJan Booij, Liesbeth Reneman, Marielle Alders, et al.Pageof 25